1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 512 F.Supp.3d
  5. 512 F.Supp.3d 546 (2021)
 

IN RE VALSARTAN PRODUCTS LIABILITY LITIGATION

Civil No. 19-2875 (RBK/JS).

512 F.Supp.3d 546 (2021)

IN RE: VALSARTAN N-NITROSODIMETHYLAMINE (NDMA), LOSARTAN, AND IRBESARTAN PRODUCTS LIABILITY LITIGATION.

United States District Court, D. New Jersey, Camden Vicinage.

Filed January 8, 2021.

This Opinion and Order addresses an incessant dispute that plagues complex litigation — that is, whether a Confidentiality designation pursuant to a Discovery Confidentiality or Protective Order is appropriate and necessary.1 Since the parties' dispute is emblematic...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases